Please try another search
Lasa Supergenerics Limited engages in the research, manufacture, and marketing of animal and human healthcare products primarily in India. It offers API products comprising fenbendazole, toldimphos sodium, cyromazine, albendazole, riclabendazole, rafoxanide, ornidazole, ricobendazole, oxfendazole, closantel base, closantel sodium, nitroxynil, halquinol, and oxyclozanide, as well as 2,6-diiodo-4-nitrophenol; and other API products. The company also provides animal feed ingredients, including calcium iodate; and reagents for therapeutic use comprising potassium iodide. It also exports its products. Lasa Supergenerics Limited was incorporated in 2016 and is based in Ratnagiri, India.
Name | Age | Since | Title |
---|---|---|---|
Omkar Pravin Herlekar | 43 | 2016 | Chairman & MD |
Hardesh Raja Tolani | - | 2017 | Non-Executive & Independent Director |
Manali Roop Bhagtani | - | 2018 | Non-Executive & Independent Director |
Ajay Hareshlal Sukhwani | 36 | 2017 | Non-Executive Independent Director |
Ekta Avtar Gurnasinghani | - | 2017 | Non-Executive & Independent Director |
Umesh Pawar | 40 | 2024 | Additional Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review